A007460 Stock Overview
Designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Aprogen Medicines Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩783.00 |
| 52 Week High | ₩1,894.00 |
| 52 Week Low | ₩701.00 |
| Beta | 0.84 |
| 1 Month Change | -34.97% |
| 3 Month Change | -35.40% |
| 1 Year Change | -18.44% |
| 3 Year Change | -84.51% |
| 5 Year Change | -90.58% |
| Change since IPO | -99.85% |
Recent News & Updates
Risks Still Elevated At These Prices As Aprogen Medicines Inc. (KRX:007460) Shares Dive 26%
Dec 19
We Think Aprogen Medicines (KRX:007460) Has A Fair Chunk Of Debt
Dec 04Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Sep 29Recent updates
Risks Still Elevated At These Prices As Aprogen Medicines Inc. (KRX:007460) Shares Dive 26%
Dec 19We Think Aprogen Medicines (KRX:007460) Has A Fair Chunk Of Debt
Dec 04Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Sep 29Is Aprogen Medicines (KRX:007460) Using Too Much Debt?
Aug 22Aprogen Medicines Inc. (KRX:007460) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected
Jul 21Aprogen Medicines Inc.'s (KRX:007460) 25% Share Price Plunge Could Signal Some Risk
May 31Is Aprogen Medicines (KRX:007460) A Risky Investment?
May 21Aprogen Medicines Inc. (KRX:007460) Investors Are Less Pessimistic Than Expected
Feb 26If You Had Bought Aprogen KIC's (KRX:007460) Shares Three Years Ago You Would Be Down 86%
Jan 07Shareholder Returns
| A007460 | KR Machinery | KR Market | |
|---|---|---|---|
| 7D | -4.0% | 5.6% | -1.9% |
| 1Y | -18.4% | 29.4% | -9.5% |
Return vs Industry: A007460 underperformed the KR Machinery industry which returned 29.4% over the past year.
Return vs Market: A007460 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A007460 volatility | |
|---|---|
| A007460 Average Weekly Movement | 9.1% |
| Machinery Industry Average Movement | 7.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A007460 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A007460's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 245 | Ki-Cheol Lim | www.aprogen-kic.com |
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers.
Aprogen Medicines Inc. Fundamentals Summary
| A007460 fundamental statistics | |
|---|---|
| Market cap | ₩218.32b |
| Earnings (TTM) | -₩42.27b |
| Revenue (TTM) | ₩147.85b |
1.5x
P/S Ratio-5.2x
P/E RatioIs A007460 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007460 income statement (TTM) | |
|---|---|
| Revenue | ₩147.85b |
| Cost of Revenue | ₩88.20b |
| Gross Profit | ₩59.66b |
| Other Expenses | ₩101.93b |
| Earnings | -₩42.27b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -151.60 |
| Gross Margin | 40.35% |
| Net Profit Margin | -28.59% |
| Debt/Equity Ratio | 25.5% |
How did A007460 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 19:18 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aprogen Medicines Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ki-jong Sung | Mirae Asset Securities Co., Ltd. |